Tca Cellular Therapyllctca Ctis A Privately Held Biotherapeutics Company Whose Mission Is To Create And Accelerate Adult Stem Cell Therapies And To Develop Next Generation Treatments For Serious And Life Threatening Diseases The Company Utilizes Single Or A Combination Of Autologouspatient S Ownadult Stem Cells To Treat Various Diseasesrelated To The Cardiovascularnervousskeletal And Muscular Systems Six Fda Approved Clinical Trials At Phases Iii And Or Ii Iii Are Underway To Treat Heart Diseaseperipheral Vascular Diseasepvd Peripheral Arterial Diseasepad Limb Ischemiaamyotrophic Lateral Sclerosisals Or Lou Gehrig S Diseaseand Spinal Cord Injuries Tca Ct S Adult Stem Cell Research Allows Us To Produce A Marketable Biological Product To Regenerate Damaged Blood Vessels And Organs As Soon As Phase Iii Studies Are Completed And Approved By The Fda For The United States Marketthe Adult Stem Cell Products Developed By Tca Ct Will Be Transplanted Into Humans As Treatments For A Variety Of Diseases
